sodium pyruvate

DRUG2 trials

Sponsors

Emphycorp, Cellular Sciences, inc.

Conditions

COVID-19Moderate Asthma

Phase 1

Safety and Efficacy Study of the Use of Sodium Pyruvate Bronchodilation in Asthmatics

TerminatedNCT00262652

EmphycorpModerate Asthma

Start: 2006-01-31End: 2006-09-30Updated: 2011-06-27

Phase 2

Sodium Pyruvate Nasal Spray Treatment of COVID-19 Infection

CompletedNCT04824365

Cellular Sciences, inc.COVID-19

Start: 2021-04-12End: 2022-08-12Updated: 2022-11-02